Cumberland Pharmaceuticals Inc.
209 10th Avenue
Suite 332
Nashville
Tennessee
37203
United States
Tel: 615-255-0068
Fax: 615-255-0094
Website: http://www.cumberlandpharma.com/
Email: mail@cumberlandpharma.com
261 articles about Cumberland Pharmaceuticals Inc.
-
Newly Published Data Demonstrates 85% Eradication of Ulcer Causing Bacteria
3/26/2018
Study supports use of Omeclamox®-Pak as first-line treatment for H. pylori
-
Cumberland Pharmaceuticals Reports 25% Revenue Growth For The Full Year 2017
3/6/2018
Cumberland Pharmaceuticals Inc. announced fourth quarter and full year 2017 financial results. Net Revenues for the year ended December 31, 2017 were $41.2 million, a 25% increase over the prior year period.
-
Cumberland Pharma Release: Newly Published Data Demonstrates Amifostine Reduces Gastro-Intestinal Toxicity for Multiple Myeloma Patients
1/30/2018
The study, led by Ehsan Malek, MD at Case Western Reserve University, assessed multiple myeloma patients receiving high dose melphalan followed by auto-HTC.
-
Cumberland Pharma Reports 27% Revenue Growth in the Third Quarter
11/8/2017
Cumberland Pharma announced third quarter 2017 financial results with Net Revenues of $11.2M, up 27% over the prior year quarter.
-
Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results
11/1/2017
A conference call and live Internet webcast will be held on Tuesday, November 7, 2017, at 4:30 p.m. Eastern Time to discuss the results.
-
Cumberland Pharmaceuticals Launches Promotion Of Totect In The U.S. For Emergency Oncology Intervention
9/25/2017
-
Clinigen And Cumberland Pharmaceuticals Launch Totect In The U.S. For Emergency Oncology Intervention
9/25/2017
-
Cumberland Pharmaceuticals Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter
8/9/2017
-
Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results
8/2/2017
-
Cumberland Pharmaceuticals Begins U.S. Shipments Of Dexrazoxane For Oncology Patient Support
7/31/2017
-
Clinigen And Cumberland Pharmaceuticals Obtain FDA Approval For Totect In The U.S.
7/10/2017
-
Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
5/16/2017
-
Cumberland Pharmaceuticals To Announce First Quarter 2017 Financial Results
5/9/2017
-
Cumberland Pharmaceuticals Release: New Kristalose Growth Driver Established Through Co-Promotion Agreement
4/26/2017
-
Cumberland Pharmaceuticals Release: Caldolor Demonstrates Significant Post Surgical Pain Reduction And Decrease In Opioid Use
3/28/2017
-
Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results
3/8/2017
-
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results
3/1/2017
-
Cumberland Pharmaceuticals Release: Caldolor Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
2/7/2017
-
U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case
1/30/2017
-
Cumberland Pharmaceuticals Release: Company Announces Kenneth J. Krogulski To Join Its Board Of Directors
1/16/2017